CG
MEDP icon

Carmignac Gestion’s Medpace MEDP Stock Holding History

Carmignac Gestion’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,733
Closed -$912K – 165
2024
Q3 		$912K Sell
2,733
-1,800
-40% -$684K 0.02% 135
2024
Q2 		$1.87M Sell
4,533
-920
-17% -$364K 0.03% 111
2024
Q1 		$2.2M Sell
5,453
-3,227
-37% -$1.13M 0.03% 96
2023
Q4 		$2.66M Buy
8,680
+965
+13% +$260K 0.04% 96
2023
Q3 		$1.87M Hold
7,715
– – 0.03% 103
2023
Q2 		$1.85M Hold
7,715
– – 0.03% 107
2023
Q1 		$1.45M Buy
7,715
+5,083
+193% +$1.05M 0.02% 106
2022
Q4 		$559K Buy
+2,632
New +$526K 0.01% 115

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Carmignac Gestion's MEDP Position: Q4 2024 in Review

Carmignac Gestion sold out of Medpace (MEDP) in Q4 2024, closing a stake of 2,733 shares — an estimated $912K sold.

Carmignac Gestion first reported a position in MEDP in Q4 2022 and held it in 8 quarters. The position peaked at $2.66M in Q4 2023. 591 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Carmignac Gestion reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Carmignac Gestion sold 2,733 Medpace shares in Q4 2024, an estimated $912K.
  • Carmignac Gestion first reported a position in Medpace in Q4 2022 and held it in 8 quarters.
  • Carmignac Gestion's Medpace position peaked at $2.66M in Q4 2023.
  • 591 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Carmignac Gestion's 13F filing for Q4 2024, filed 13 Feb 2025.